Early initiation for endless
Possibilities
FOR PEOPLE WITH UNCONTROLLED TYPE 2 DIABETES
3mg|7mg|14mg
A GAME CHANGER. A LIFE CHANGER
Early Initiation with Rybelsus® for
broad range of benefits
8 out of 10
PwDs achieved
glycaemic
target of <7%*10
glycaemic
target of <7%*10
1 in 3
PwDs achieved a
weight loss
of ≥5%#10
weight loss
of ≥5%#10
*%* when oral semaglutide is initiated within 1 year of T2D diagnosis3
#achieved a glycemic target of <6%
This is a model and not a patient
#achieved a glycemic target of <6%
This is a model and not a patient
Early achievement of near-normal HbA1c is associated with a reduced risk of
future complications in type 2 diabetes (T2D).7
future complications in type 2 diabetes (T2D).7
PIONEER 1 post-hoc analysis looked at the impact of early initiation (within 1
year of T2D diagnosis) of oral semaglutide on glycemic efficacy, body weight
and achievement of targets in drug-naïve people with T2D on diet and exercise.7
year of T2D diagnosis) of oral semaglutide on glycemic efficacy, body weight
and achievement of targets in drug-naïve people with T2D on diet and exercise.7
A high proportion of patients initiating oral semaglutide within ≤1 year of T2D diagnosis reached glycemic target of <6% in 45% of pts on oral sema 14 mg (vs
31% in the >1 year group).7
31% in the >1 year group).7
